Evidence map›Paper›PMID 27295268›Full record

ArticleBone marrow transplantation2016

GvHD prophylaxis with tacrolimus plus sirolimus after reduced intensity conditioning allogeneic transplantation: results of a multicenter study.

R Parody, L López-Corral, O Lopez-Godino, C Martinez, R Martino, C Solano, P Barba, D Caballero, I García-Cadenas, J L Piñana and 6 more

Abstract readLetterMulticenter Study
PubMed Publisher
In one paragraph

Article in Bone marrow transplantation, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

R ParodyHospital Universitario Virgen del Rocío/Virgen Macarena, Instituto de Biomedicina de Sevilla (IBIS), Universidad de Sevilla, Sevilla, Spain.
L López-CorralHospital Universitario de Salamanca, Salamanca, Spain.
O Lopez-GodinoHospital Universitario de Salamanca, Salamanca, Spain.
C MartinezHospital Clinic de Barcelona, Barcelona, Spain.
R MartinoHospital de la Santa Creu i Sant Pau, IIB Sant Pau and Jose Carreras Institute, Universidad Autónoma de Barcelona, Barcelona, Spain.
C SolanoHospital Clínico de Valencia, Valencia, Spain.
P BarbaHospital Vall d'Hebron, Barcelona, Spain.
D CaballeroHospital Universitario de Salamanca, Salamanca, Spain.
I García-CadenasHospital de la Santa Creu i Sant Pau, IIB Sant Pau and Jose Carreras Institute, Universidad Autónoma de Barcelona, Barcelona, Spain.
J L PiñanaHospital Clínico de Valencia, Valencia, Spain.
F J Marquez-MalaverHospital Universitario Virgen del Rocío/Virgen Macarena, Instituto de Biomedicina de Sevilla (IBIS), Universidad de Sevilla, Sevilla, Spain.
L VazquezHospital Universitario de Salamanca, Salamanca, Spain.
A EsquirolHospital de la Santa Creu i Sant Pau, IIB Sant Pau and Jose Carreras Institute, Universidad Autónoma de Barcelona, Barcelona, Spain.
J C H BoludaHospital Clínico de Valencia, Valencia, Spain.
F Sanchez-GuijoHospital Universitario de Salamanca, Salamanca, Spain.
J A Pérez-SimonHospital Universitario Virgen del Rocío/Virgen Macarena, Instituto de Biomedicina de Sevilla (IBIS), Universidad de Sevilla, Sevilla, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdolescentAdultAgedFemaleGraft vs Host DiseaseHematologic NeoplasmsHematopoietic Stem Cell TransplantationHumansImmunosuppressive AgentsMaleMiddle AgedSirolimusSurvival AnalysisTacrolimusTransplantation ConditioningTransplantation, HomologousImmunosuppressive AgentsSirolimusTacrolimus

Identifiers

PMID27295268

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.